The Lancet: A third of COVID-19 survivors will be diagnosed with neuropsychiatric symptoms within 6 months

In COVID-19 since the outbreak of the pandemic, researchers have been exploring the continuing impact of the new virus crown survivors of mental health, there is now a new study to discover more details.

DOI: org/10.

They estimated the incidence of 14 neurological and psychiatric symptoms in COVID-19 patients within 6 months after diagnosis: intracranial hemorrhage; ischemic stroke ; Parkinson's disease; Guillain-Barré syndrome; nerves, nerve roots, and nerve plexus Diseases; spinal cord and muscle diseases; encephalitis; dementia; psychosis, mood and anxiety disorders (groups and alone); drug use disorders; insomnia.

Using the Cox model, the researchers compared the incidence of the above-mentioned symptoms in patients with COVID-19 and influenza or other respiratory infections.

The results showed that among the 236 379 COVID-19 confirmed patients, the estimated incidence of neurological or psychiatric diagnosis in the following 6 months was 33.

Proportion of major neuropsychiatric symptoms in non-hospitalization, hospitalization, ITU, and encephalopathy patients during the onset of illness within 6 months after infection

17.

The diagnosis of neurological diseases is relatively rare.

Comparing with the data of people who recovered from other respiratory infections during the same time period, it was found that COVID-19 survivors had a higher incidence of psychological and neurological diseases [(hazard ratio [HR] 1.

Comparing with the data of people who recovered from other respiratory infections in the same time period, it was found that COVID-19 survivors have a higher incidence of psychological and neurological diseases.

But in fact there are some other studies that are consistent with the results of the Lancet.

doi: 10.

In short, the results of this research can help the medical system plan how to address the psychological needs of COVID-19 survivors.